AG
EVH icon

Algert Global’s Evolent Health EVH Stock Holding History

Algert Global’s Portfolio EVH Stock Details EVH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$3.56M Buy
+656,463
New +$2.52M 0.04% 667
2025
Q3 		– Sell
-191,581
Closed -$2.16M – 1188
2025
Q2 		$2.16M Hold
191,581
– – 0.05% 610
2025
Q1 		$1.81M Buy
+191,581
New +$1.94M 0.04% 624
2024
Q4 		– Sell
-23,025
Closed -$651K – 1218
2024
Q3 		$651K Buy
23,025
+12,570
+120% +$324K 0.02% 848
2024
Q2 		$200K Buy
+10,455
New +$267K 0.01% 1281
2024
Q1 		– Sell
-38,590
Closed -$1.27M – 1129
2023
Q4 		$1.27M Sell
38,590
-30,549
-44% -$864K 0.05% 556
2023
Q3 		$1.88M Buy
+69,139
New +$1.92M 0.09% 378
2023
Q1 		– Sell
-29,094
Closed -$817K – 1176
2022
Q4 		$817K Hold
29,094
– – 0.05% 644
2022
Q3 		$1.04M Buy
+29,094
New +$1.02M 0.06% 525
2022
Q2 		– Sell
-32,754
Closed -$1.06M – 1256
2022
Q1 		$1.06M Buy
32,754
+18,350
+127% +$480K 0.07% 497
2021
Q4 		$399K Hold
14,404
– – 0.05% 623
2021
Q3 		$447K Buy
+14,404
New +$346K 0.06% 576
2020
Q1 		– Sell
-14,333
Closed -$130K – 441
2019
Q4 		$130K Buy
+14,333
New +$116K 0.04% 339

Other funds holding EVH

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
CCM
Cadian Capital Management New York $1.32B AUM 4.19% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return
RF
Rubicon Founders Nashville, Tennessee $196M AUM 53.12% 1-Year Est. Return
EC
Engaged Capital Newport Beach, California $327M AUM 22.96% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Marshall Wace
Marshall Wace London, United Kingdom $127B AUM 46.06% 1-Year Est. Return
Nuveen
Nuveen Charlotte, North Carolina $419B AUM 43.02% 1-Year Est. Return

Algert Global's EVH Position: Q2 2026 in Review

Algert Global opened a new position in Evolent Health (EVH) in Q2 2026: 656,463 shares worth $3.56M. The stake represents 0.04% of the portfolio and ranks #667 among its holdings. This is a return to the name: Algert Global previously reported a position in EVH as recently as Q2 2025.

Algert Global first reported a position in EVH in Q4 2019 and has held it in 13 quarters since. 199 funds tracked by Wall St. Rank hold EVH as of Q2 2026.

  • Algert Global held 656,463 shares of Evolent Health worth $3.56M as of Q2 2026.
  • Evolent Health was a new Algert Global position in Q2 2026.
  • Evolent Health made up 0.04% of Algert Global's portfolio in Q2 2026, its #667 holding.
  • Algert Global first reported a position in Evolent Health in Q4 2019 and has held it in 13 quarters since.
  • 199 funds tracked by Wall St. Rank held Evolent Health as of Q2 2026.

Based on Algert Global's 13F filing for Q2 2026, filed 13 Aug 2026.